Pharmaceutical tablet

Karolak , et al. October 6, 2

Patent Grant D601689

U.S. patent number D601,689 [Application Number D/268,559] was granted by the patent office on 2009-10-06 for pharmaceutical tablet. This patent grant is currently assigned to Glaxo Group Limited. Invention is credited to Wlodek Karolak, Helen Anne Willy.


United States Patent D601,689
Karolak ,   et al. October 6, 2009

Pharmaceutical tablet

Claims

CLAIM The ornamental design for a pharmaceutical tablet, as shown and described.
Inventors: Karolak; Wlodek (Mississauga, CA), Willy; Helen Anne (Harlow, GB)
Assignee: Glaxo Group Limited (Middlesex, GB)
Appl. No.: D/268,559
Filed: November 9, 2006

Foreign Application Priority Data

May 12, 2006 [GB] 3024830
Current U.S. Class: D24/101
Current International Class: 2801
Field of Search: ;D24/100-104 ;D28/4,8.1,8.2 ;424/464-485,453,438,732,451 ;D1/100,121,125-128,112,108 ;D21/440 ;426/78

References Cited [Referenced By]

U.S. Patent Documents
1419618 June 1922 Deming
1580576 April 1926 Weidner
2102885 December 1937 Carroll
2340037 January 1944 Zipper
3048526 August 1962 Boswell
3620759 November 1971 Maddox
3702653 November 1972 Motten
D235215 May 1975 Larson
D258091 January 1981 Reed et al.
4376111 March 1983 Tovey
D269718 July 1983 Tovey
D269721 July 1983 Tovey
D269722 July 1983 Tovey
D274846 July 1984 Eoga
D283649 April 1986 Casberg
4601896 July 1986 Nugent
D285363 August 1986 Tovey
D286085 October 1986 Tovey
4643731 February 1987 Eckenhoff
4735805 April 1988 Ni et al.
4883182 November 1989 Hughes
D376643 December 1996 Hatton et al.
D420464 February 2000 Binstock et al.
D520635 May 2006 Bonny et al.
D530814 October 2006 Bonny et al.
D535741 January 2007 Stawski et al.
D556946 December 2007 Seum et al.
D564086 March 2008 Nielsen et al.
Primary Examiner: Simmons; Ian
Assistant Examiner: Hanson; Charles D
Attorney, Agent or Firm: Nixon & Vanderhye P.C.

Description



The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front perspective view of a pharmaceutical tablet showing our new design;

FIG. 2 is a top view thereof;

FIG. 3 is a bottom view thereof;

FIG. 4 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 5 is a cross-sectional view through section 5--5 of FIG. 1;

FIG. 6 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 7 is a top view thereof;

FIG. 8 is a bottom view thereof;

FIG. 9 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 10 is a cross-sectional view through section 10--10 of FIG. 6;

FIG. 11 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 12 is a top view thereof;

FIG. 13 is a bottom view thereof;

FIG. 14 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 15 is a cross-sectional view through section 15--15 of FIG. 11;

FIG. 16 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 17 is a top view thereof;

FIG. 18 is a bottom view thereof;

FIG. 19 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 20 is a cross-sectional view through section 20--20 of FIG. 16;

FIG. 21 is a front perspective view of am alternate embodiment of the design of FIG. 1;

FIG. 22 is a top view thereof;

FIG. 23 is a bottom view thereof;

FIG. 24 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 25 is a cross-sectional view through section 25--25 of FIG. 21;

FIG. 26 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 27 is a top view thereof;

FIG. 28 is a bottom view thereof;

FIG. 29 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 30 is a cross-sectional view through section 30--30 of FIG. 26;

FIG. 31 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 32 is a top view thereof;

FIG. 33 is a bottom view thereof;

FIG. 34 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 35 is a cross-sectional view through section 35--35 of FIG. 31;

FIG. 36 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 37 is a top view thereof;

FIG. 38 is a bottom view thereof;

FIG. 39 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 40 is a cross-sectional view through section 40--40 of FIG. 36;

FIG. 41 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 42 is a top view thereof;

FIG. 43 is a bottom view thereof;

FIG. 44 is a front view thereof, with the left side, right side and rear views thereof being identical thereto;

FIG. 45 is a cross-sectional view through section 45--45 of FIG. 41;

FIG. 46 is a front perspective view of an alternate embodiment of the design of FIG. 1;

FIG. 47 is a top view thereof;

FIG. 48 is a bottom view thereof;

FIG. 49 is a front view thereof, with the left side, right side and rear views thereof being identical thereto; and,

FIG. 50 is a cross-sectional view through section 50--50 of FIG. 46.

The different styles of shading in FIGS. 16 20 depict a color contrast, and are not indicative of any specific color.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed